437703-64-5

Basic information

• Product Name: [1,2,4]Triazolo[1,5-a]pyridine-7-carboxylic acid, 5-amino-2-phenyl-, methyl ester
• CAS NO: 437703-64-5
• Molecular Formula: C14H12N4O2
• Molecular Weight: 268.275
• Mol File: 437703-64-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [1,2,4]Triazolo[1,5-a]pyridine-7-carboxylic acid, 5-amino-2-phenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [1,2,4]Triazolo[1,5-a]pyridine-7-carboxylic acid, 5-amino-2-phenyl-, methyl ester(437703-64-5)
• EPA Substance Registry System: [1,2,4]Triazolo[1,5-a]pyridine-7-carboxylic acid, 5-amino-2-phenyl-, methyl ester(437703-64-5)

Safety Data

• Hazardous Substances Data: 437703-64-5(Hazardous Substances Data)

Upstream product

• 98547-97-8 2,6-diaminopyridine-4-carboxylic acid methyl ester 
• 100-52-7 benzaldehyde 
• 5398-44-7 2,6-dichloropyridine-4-carboxylic acid 
• 6313-56-0 2,6-diamino-4-pyridinecarboxylic acid 

Relevant articles and documents

Lead generation: Sowing the seeds for future success

Lead generation and the associated hit-to-lead process are key strategic elements in modern pharmaceutical research, and most companies have implemented this concept. Efficient lead generation is one of the main attempts to reduce the high attrition rates observed along the drug discovery process by focussing on the early developmental phases. The level of integration of the lead generation activities within the discovery organization, the flexibility in assessing and implementing new chemistries and new technologies, the high-quality standards set for the identification of the best possible chemical lead series will ultimately determine the future success in discovering new medicines.

Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands

Substituted [1,2,4]triazolo[1,5a]pyridine derivatives and pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are useful for treatment of diseases responsive to modulation of the adenosine recep